Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Quotazioni in diretta
| Data | Ora | Fonte | Titolo |
|---|---|---|---|
| 25/11/2024 | 12:02 | EDGAR2 | Form 8-K - Current report |
| 14/11/2024 | 22:05 | GLOBE | Alumis Presents Data Highlighting ESK-001’s Potential as a.. |
| 13/11/2024 | 22:24 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/11/2024 | 22:14 | EDGAR2 | Form 8-K - Current report |
| 13/11/2024 | 22:05 | GLOBE | Alumis Reports Third Quarter 2024 Financial Results and.. |
| 04/11/2024 | 14:00 | GLOBE | Alumis to Participate in Guggenheim's Inaugural Healthcare.. |
| 27/9/2024 | 15:00 | GLOBE | Late-Breaking Data at EADV of ESK-001, an Oral TYK2.. |
| 03/9/2024 | 22:29 | GLOBE | Alumis to Participate in Upcoming September Investor.. |
| 13/8/2024 | 22:05 | GLOBE | Alumis Reports Second Quarter 2024 Financial Results and.. |
| 29/7/2024 | 14:00 | GLOBE | Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating.. |
| 28/6/2024 | 05:57 | GLOBE | Alumis Announces Pricing of Initial Public Offering |
| Apertura: 9,77 | Min: 9,21 | Max: 9,77 |
| Chiusura: 9,72 |
|
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni |
|
ADVFN Network
|
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
